Gross Margin

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

A new partnership aims to bring industrial-scale, clean-label cannabis extraction to the Garden State, promising a new standard for purity and consistency.

The firm leveraged its integrated insurance and investment model to achieve record revenue and a top-10 ranking while defying a looming advisor shortage.

As AI agents drive up costs and create a 'token shortage,' a new player unveils a distributed compute network to challenge the centralized cloud model.

Erdene begins gold production at its new Bayan Khundii mine, generating $31M in revenue while advancing major copper and molybdenum projects in Mongolia.

Amid a full-year revenue drop, the EdTech firm unveils a new AI product, banking on innovation and a new business model to chart a path to profitability.

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

As oncologists warn of supplement risks, one company founded by a doctor and caregiver aims to provide a safer, transparent path for cancer survivors.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A Vancouver firm's revolutionary tech, backed by government funds, aims to decarbonize metal recovery and secure North America's platinum supply chain.

A new platform combines proprietary AI with human agents to tackle healthcare's administrative mess. But can it truly streamline care and improve outcomes?

Capstone Holding Corp. merges Midwest operations, targeting positive EBITDA by 2026 amid major project wins and a disciplined cost-cutting campaign.

The non-prime lender struck a deal with lenders to ensure liquidity, but it comes at a high price amid massive loan losses and scrutiny of its LendCare unit.

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

Israel's kosher food giant rewards shareholders with a hefty dividend, backed by record profits and demonstrating resilience in a volatile global market.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

Singapore's HomesToLife nearly doubles its net profit, fueled by a key acquisition and strong exports, defying global market headwinds that have hit rivals.

With the appointment of Jack Azagury as CEO, Insight Enterprises signals an aggressive pivot to AI, banking on his transformation expertise to lead a new era.

FeiyuTech's new Pocket 4 gimbal camera, unveiled at AWE 2026, packs a 48MP sensor and on-device AI to challenge DJI's market dominance.